Receptos, Inc. 4
4 · Receptos, Inc. · Filed Sep 24, 2014
Insider Transaction Report
Form 4
Receptos, Inc.RCPT
Torres S. Edward
Director
Transactions
- Sale
Common Stock
2014-09-22$63.08/sh−14,318$903,179→ 1,052,749 total(indirect: See footnote) - Sale
Common Stock
2014-09-23$61.07/sh−85,682$5,232,600→ 967,067 total(indirect: See footnote)
Footnotes (3)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.12 per share, inclusive. The reporting person undertakes to provide to Receptos, Inc., any security holder of Receptos, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.
- [F2]These shares are owned directly by Lilly Ventures Fund I LLC (the "Fund"). Eli Lilly and Company, as sole Managing Member of the Fund, and pursuant to provisions of the LLC Agreement of the Fund, has voting authority with respect to shares owned by the Fund. S. Edward Torres is a non-managing member of the Fund and may be deemed to beneficially own the shares. Mr. Torres disclaims beneficial ownership of the shares held of record by the Fund, except to the extent of his pecuniary interest therein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.86 to $62.10, inclusive.